Login

VIROPHARMA INC 3 SEC Filings

Filed On Filing
22 Aug 2012 Form 3: Kirby John J., V.P., Chief Accounting Officer

No securities owned

04 Jan 2012 Form 3: McHugh Julie, Director

No securities owned

04 Jan 2011 Form 3: Fletcher Robert C., V.P., Business Development
08 Jun 2009 Form 3: Baldino Frank Jr, Director

No securities owned

08 May 2009 Form 3: Baker Brothers Life Sciences Capital (GP), Llc, 10% owner and 2 others

Holds 6,039,675 shares of Common Stock

08 May 2009 Form 3: 14159 capital (GP), Llc, 10% owner and 2 others

Holds 157,067 shares of Common Stock

08 May 2009 Form 3: Baker Biotech Capital (GP), Llc, 10% owner and 2 others

Holds 1,893,795 shares of Common Stock

08 May 2009 Form 3: Baker Bros. Capital (GP), Llc, 10% owner and 2 others

Holds 105,105 shares of Common Stock

08 May 2009 Form 3: Baker / Tisch Capital (GP), Llc, 10% owner and 2 others

Holds 81,950 shares of Common Stock

21 Oct 2008 Form 3: Rowland Charles A Jr, Chief Financial Officer

No securities owned

18 Apr 2008 Form 3: Morris Richard Steven, Chief Accounting Officer

Holds 2,592 shares of Common Stock

03 Jan 2008 Form 3: Wolf John Peter Iii, VP, General Counsel

No securities owned

02 May 2007 Form 3: Pietrusko Robert, VP, Regulatory & Quality

No securities owned

23 Mar 2007 Form 3: Baker Bros. Capital (GP), Llc, 10% owner and 2 others
23 Mar 2007 Form 3: Baker Biotech Capital (GP), Llc, 10% owner and 2 others
23 Mar 2007 Form 3: 14159 capital (GP), Llc, 10% owner and 2 others
23 Mar 2007 Form 3: Baker Brothers Life Sciences Capital (GP), Llc, 10% owner and 2 others
07 Nov 2006 Form 3: Soland Daniel B, VP, Chief Commercial Officer

No securities owned

23 May 2006 Form 3: Pien Howard H, Director

No securities owned

23 Jan 2006 Form 3: Leone John R, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support